Ashwagandha Extract

Ashwaganda is a plant (Latin name Withania somnifera) that grows in India and North Africa. The word literally means ‘scent of a horse’ which refers to the smell of the roots as well as the stamina of a horse.

As a nootropic, Ashwagandha has a powerful effect. Ashwagandha is an adaptogenic herb traditionally used to help maintain a healthy balance between body and mind. It is often used as a natural sedative[1].

What is Ashwagandha?

Ashwagandha, the first recognized herb of Ayurveda, has been called the “king of all herbs” and has been used and cultivated in India for centuries. A powerhouse of natural antioxidants, this botanical herb is known to promote relaxation, improve memory and cognition, and reduce stress and anxiety[1]. In Ayurveda, Withania somnifera, also known as Ashwagandha or Indian ginseng is considered a “rasayana” herb, meaning “path of the essence” in Sanskrit. Rasayana herbs prolong life according to Ayurveda and ensure a natural balance in the body.


Ashwagandha can be taken as a supplement, or in the form of tea. Ashwagandha is a GABA mimetic, meaning it has an effect on GABA in the central nervous system. GABA is the main inhibitory neurotransmitter in the central nervous system. GABA is responsible for regulating anxiety and stress levels, and is especially effective in combating insomnia. Ashwagandha also has an effect on serotonin and dop@mine levels. Ashwagandha increases the concentration of serotonin in the hippocampus. This area of ​​the brain is responsible for happiness, positive moods and memories[1].

[1] Health claims pending approval by the European Commission.

External Resources

Legally, Next Valley is not allowed to make statements about the properties and uses of Ashwagandha Extract if they have not been approved as a health claim by the European Commission.

For more information, we refer you to external sources.


Different doses were used in the different studies of Ashwagandha. Between 50 mg and no less than 6000 mg per day are mentioned: usually divided into 3 smaller doses. When you combine Ashwagandha with other nootropics, a lower dose is probably sufficient. Ingestion is best done with food. Be careful when using other medicines and always start with a low dose to test what Ashwagandha does for you.

Side effects

At average doses (between 400 mg and 1600 mg per day), Ashwagandha is well accepted. There are no serious side effects to report. Sometimes diarrhea, abdominal pain and drowsiness occur. Often these effects are minimal and temporary. If you notice any side effects, reduce the dose. The use of ashwagandha is not recommended for children and pregnant women because no data are available yet on the use of Ashwagandha in this target group.


Recommended daily dose: 1 to 3 capsules

Ingredients per 1 capsule.

400mg Ashwagandha Extract (2.5% Withanolides)

Gelatin capsule
StarCap 1500® (capsule filler)

Instructions for use

Do not use if you are under 18, or if you are pregnant or breastfeeding. Do not use if you have high blood pressure or medical complications. Always consult an expert before using new food supplements. A healthy lifestyle is important, as is a varied, balanced diet for which supplements are no substitute. Do not exceed recommended dosage.

Recommended dosage: As a dietary supplement for adults, take 1 to 2 capsules daily, preferably on an empty stomach for best effect.

Keep cool, dry and closed.

Certificate of Analysis

A Certificate of Analysis may sometimes be referred to as a COA, a CofA, a Certificate of Conformity, or a Certificate of Conformity. It is a document certifying that a product delivered meets the specifications of the recipient.

Certificate of Analysis for Ashwagandha Extract

The content of a Certificate of Analysis varies by industry and product category. Below we discuss the content of a COA that is generally accepted for the raw materials processed in Next Valley products.

What is a Certificate of Analysis?

What is a health claim?

A health claim is any statement about a relationship between nutrition and health.

Next Valley is legally prohibited from making statements about properties and uses of Ashwagandha if they have not been approved as a health claim by the European Commission.

The European Commission approves various health claims, provided they are based on scientific evidence and can be easily understood by consumers. The European Food Safety Authority (EFSA) is responsible for evaluating the scientific evidence to support health claims.

The scientific evidence is provided by the health claim applicant. These examinations are usually carried out by the applicant or are known at the time of the application. New studies are only included in the evaluation by EFSA if a new application is made.

The European food and commodity authority EFSA has not yet issued an opinion on herbal preparations or botanicals, so the European Commission has not yet issued a decision. The health claims for botanicals submitted to EFSA are therefore still ‘on hold’, the evaluation is ongoing.

Claim: Supports in periods of mental and nervous tension and anxiety / Contributes to optimal relaxation / Helps to support relaxation, mental and physical well-being / Contributes to emotional balance and general well-being
Claim ID: 2183
Source EFSA:
EFSA conclusion: Evaluation health claim is ongoing

Claim: Has a beneficial effect on the heart and cardiovascular system
Claim ID: 2503
Source EFSA:
EFSA conclusion: Evaluation health claim is ongoing

Claim: Ashwagandha has adaptogenic properties
Claim ID: 3251
Source EFSA:
EFSA conclusion: Evaluation health claim is ongoing

Claim: A beneficial physiological effect related to antioxidant activity, antioxidant content or antioxidant properties
Claim ID: 4507
Year of evaluation: 2010
Source EFSA: j.efsa.2010.1752
EFSA conclusion: The EFSA evaluation has not yet been adopted by the European Commission
The claimed effects are “antioxidant”, “antioxidative capacity”, “antioxidant properties”, “antioxidant activity”, “purifying/detoxifying properties” and “antioxidant activity”. The target audience is assumed to be the general population. The panel believes that claims about the capacity/antioxidant content or properties of foods/nutrients based on their ability to scavenge free radicals in vitro refer to a food/food ingredient property measured in model systems. It is not apparent from the information provided that this ability as such has a beneficial physiological effect in humans. No evidence has been provided that having antioxidant activity/content and/or antioxidant properties is a beneficial physiological effect.

Based on the data presented, the panel concludes that a cause-and-effect relationship has not been established between the consumption of the food(s) / food ingredient(s) covered by this advisory and a beneficial physiological effect related to antioxidant activity, content of antioxidants or antioxidant properties.